Security Snapshot

PETMED EXPRESS INC - Common Stock, $0.001 par value per share (PETS) Institutional Ownership

CUSIP: 716382106

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

48

Shares (Excl. Options)

5,973,855

Price

$2.28

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
PETS on Nasdaq
Shares outstanding
21,407,486
Price per share
$2.29
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
5,973,855
Total reported value
$13,717,489
% of total 13F portfolios
0%
Share change
-940,093
Value change
-$2,446,794
Number of holders
48
Price from insider filings
$2.29
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • PETS - PETMED EXPRESS INC - Common Stock, $0.001 par value per share is tracked under CUSIP 716382106.
  • 48 institutions reported positions in Q1 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 50 to 48 between Q4 2025 and Q1 2026.
  • Reported value moved from $22,202,781 to $13,717,489.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 48 institutions filings for Q1 2026.

Open SEC Evidence

Security key

716382106

Latest holder period

Q1 2026

13F holders

48

13D/G owners

4

CIK / CUSIP context first

Significant Owners of PETMED EXPRESS INC - Common Stock, $0.001 par value per share (PETS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Silvercape Investments Ltd 12% +11% $7,481,118 +$810,196 2,579,696 +12% SilverCape Investments Limited 09 Dec 2025
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 4.7% $3,389,878 974,103 Hotchkis and Wiley Capital Management, LLC 31 Dec 2024
VANGUARD GROUP INC 4.7% $3,354,901 964,052 The Vanguard Group 31 Dec 2024
Diveroli Investment Group LLC 1.8% $1,300,633 391,757 Diveroli Investment Group LLC 11 Jan 2025

As of 31 Mar 2026, 48 institutional investors reported holding 5,973,855 shares of PETMED EXPRESS INC - Common Stock, $0.001 par value per share (PETS). This represents 28% of the company’s total 21,407,486 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of PETMED EXPRESS INC - Common Stock, $0.001 par value per share (PETS) together control 28% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RENAISSANCE TECHNOLOGIES LLC 5.5% 1,186,369 -3.3% 0% $2,704,921
VANGUARD CAPITAL MANAGEMENT LLC 3.9% 831,431 0% 0% $1,895,663
FEDERATED HERMES, INC. 3.1% 666,805 +6.2% 0% $1,520,316
BlackRock, Inc. 2.6% 551,677 +0.67% 0% $1,257,823
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.4% 514,543 -35% 0% $1,173,158
UBS Group AG 1.1% 233,676 -29% 0% $532,781
GEODE CAPITAL MANAGEMENT, LLC 1% 221,522 +7.8% 0% $505,206
DIMENSIONAL FUND ADVISORS LP 0.97% 207,769 -49% 0% $473,674
STEEL PARTNERS HOLDINGS L.P. 0.9% 193,664 0% 0.46% $441,554
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.62% 132,724 +5% 0.01% $302,611
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.59% 126,774 -28% 0% $289,045
PRICE T ROWE ASSOCIATES INC /MD/ 0.56% 120,055 0% 0% $274,000
VANGUARD FIDUCIARY TRUST CO 0.51% 109,712 0% 0% $250,143
Rangeley Capital, LLC 0.51% 109,208 +46% 0.27% $248,994
Formidable Asset Management, LLC 0.49% 105,201 +13% 0.05% $336,643
STATE STREET CORP 0.49% 105,173 0% 0% $239,794
CITADEL ADVISORS LLC 0.41% 87,894 -66% 0% $200,398
Empowered Funds, LLC 0.35% 75,024 0% $171,055
AMERIPRISE FINANCIAL INC 0.34% 73,400 -29% 0% $167,352
GROUP ONE TRADING LLC 0.33% 71,117 +2197% 0.01% $162,147
UMB Bank, n.a. 0.28% 60,000 0% 0% $136,800
NORTHERN TRUST CORP 0.22% 47,074 -20% 0% $107,329
BLAIR WILLIAM & CO/IL 0.14% 30,400 0% $69,312
SEI INVESTMENTS CO 0.11% 23,000 +42% 0% $52,440
AMERICAN CENTURY COMPANIES INC 0.11% 22,703 -62% 0% $51,763

Institutional Holders of PETMED EXPRESS INC - Common Stock, $0.001 par value per share (PETS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 5,973,855 $13,717,489 -$2,446,794 $2.28 48
2025 Q4 6,958,110 $22,202,781 -$128,779 $3.20 50
2025 Q3 6,977,259 $17,594,055 -$1,201,821 $2.51 58
2025 Q2 7,375,436 $24,585,642 -$1,852,844 $3.32 64
2025 Q1 7,865,569 $32,955,520 -$4,830,840 $4.19 72
2024 Q4 8,975,229 $43,264,129 -$2,056,912 $4.82 86
2024 Q3 9,499,069 $34,955,912 -$9,644,338 $3.68 92
2024 Q2 12,062,004 $48,853,657 -$10,510,852 $4.05 116
2024 Q1 14,628,259 $70,068,794 -$7,859,398 $4.79 112
2023 Q4 15,509,467 $117,253,738 +$12,602,057 $7.56 129
2023 Q3 13,258,944 $135,901,539 -$32,574,245 $10.25 137
2023 Q2 15,760,896 $217,549,589 -$24,550,420 $13.79 148
2023 Q1 17,308,637 $281,093,086 +$9,030,233 $16.24 163
2022 Q4 16,715,209 $295,885,547 +$3,841,866 $17.70 158
2022 Q3 16,383,469 $319,884,926 -$27,418,578 $19.52 159
2022 Q2 17,760,121 $353,462,234 +$13,809,440 $19.90 158
2022 Q1 17,076,732 $440,712,342 +$3,458,908 $25.80 166
2021 Q4 16,949,737 $428,255,284 +$6,430,707 $25.26 171
2021 Q3 16,656,564 $447,492,163 -$30,441,331 $26.87 177
2021 Q2 17,710,744 $563,648,886 +$37,310,655 $31.85 187
2021 Q1 16,386,791 $575,952,684 -$52,856,316 $35.17 198
2020 Q4 18,057,333 $578,750,488 -$16,151,108 $32.06 204
2020 Q3 18,602,966 $587,963,793 -$9,681,690 $31.62 198
2020 Q2 18,767,976 $668,677,282 +$61,033,275 $35.64 218
2020 Q1 16,894,329 $486,188,282 -$16,414,744 $28.78 196
2019 Q4 17,865,038 $420,743,094 -$4,689,801 $23.52 185
2019 Q3 17,955,094 $323,537,814 -$36,081,128 $18.02 161
2019 Q2 20,791,981 $325,743,040 -$1,751,787 $15.67 178
2019 Q1 20,034,645 $456,405,810 -$33,972,765 $22.78 195
2018 Q4 21,473,605 $499,431,923 +$28,998,363 $23.26 193
2018 Q3 19,624,210 $647,747,978 -$5,130,899 $33.01 192
2018 Q2 19,208,344 $845,955,034 -$23,381,743 $44.05 202
2018 Q1 19,788,521 $826,137,413 +$37,342,070 $41.75 201
2017 Q4 18,881,373 $859,176,999 -$67,881,141 $45.50 192
2017 Q3 20,603,806 $683,131,203 +$137,030,567 $33.15 176
2017 Q2 16,237,233 $659,339,729 +$49,746,324 $40.60 173
2017 Q1 15,343,685 $309,233,201 +$51,518,592 $20.14 148
2016 Q4 14,993,626 $345,963,268 +$4,302,139 $23.07 147
2016 Q3 15,111,591 $306,447,383 -$6,622,514 $20.28 148
2016 Q2 15,613,444 $293,016,607 -$18,957,604 $18.76 156
2016 Q1 16,454,956 $294,676,235 -$7,537,257 $17.91 152
2015 Q4 16,911,576 $289,924,561 -$12,599,706 $17.14 151
2015 Q3 17,569,776 $282,883,139 +$21,279,055 $16.10 148
2015 Q2 16,224,138 $279,988,518 +$23,771,233 $17.27 141
2015 Q1 14,494,500 $239,088,635 +$11,199,229 $16.52 140
2014 Q4 13,838,013 $199,017,063 +$7,479,602 $14.37 116
2014 Q3 13,290,404 $180,737,136 -$984,959 $13.60 120
2014 Q2 13,364,964 $180,150,971 -$7,125,290 $13.48 124
2014 Q1 13,882,037 $186,305,464 -$16,467,324 $13.41 127
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .